AUS
NZ
UK
CA
USA
IND
Highlights:
- Revolution Medicines stock opened at $40.99.
- The company has a market capitalization of $6.90 billion.
- RVMD stock has a 12-month low of $26.95 and a 12-month high of $62.40.
Revolution Medicines (NASDAQ:RVMD) is a company in the biotechnology sector. As of the latest trading session, RVMD stock opened at a price of $40.99. The company operates within the field of drug development, focusing on targeted therapies for cancer. Revolution Medicines has a notable presence in the biotech industry, attracting attention for its innovative approaches and efforts to address unmet medical needs in oncology.
Stock Performance and Key Metrics
The company’s market capitalization currently stands at $6.90 billion. A P/E ratio of -11.42 indicates that the company is currently operating at a loss relative to its stock price. RVMD stock also has a beta of 1.46, suggesting that it is more volatile compared to the broader market. The stock has experienced fluctuations over the past year, with a 12-month low of $26.95 and a high of $62.40. These figures highlight the range of movement in the stock's value over this period.
Moving Averages
The 50-day moving average for RVMD stock is recorded at $46.66, while the 200-day moving average stands at $46.75. Moving averages are often used as indicators of stock performance over different time frames, with the 50-day providing insight into more recent trends and the 200-day showing longer-term patterns. The close proximity of these averages suggests relatively consistent pricing over the observed period.
Volatility and Market Sensitivity
With a beta of 1.46, Revolution Medicines stock reflects a higher sensitivity to market movements. A beta value above 1.0 indicates that the stock tends to experience larger price swings in response to changes in the broader market. This level of volatility may appeal to market participants with a higher risk tolerance, as the stock is likely to move more dramatically compared to the general market trends.
Market Activity and Trading Range
Revolution Medicines stock has demonstrated significant movement within the past 12 months, as reflected by its high and low points. At its peak, the stock reached $62.40, while its lowest point in the same period was $26.95. These extremes illustrate the stock's susceptibility to broader market factors, company performance, and sector-wide trends. The company's performance will likely continue to be influenced by ongoing developments in its clinical trials and broader industry movements.
